Hyperbaric oxygen for intracranial abscess | Canada Hyperbarics Skip to main content
Review Undersea Hyperb Med 2021

Hyperbaric oxygen for intracranial abscess

Tomoye EO, Murphy-Lavoie HM. — Undersea Hyperb Med, 2021

Tier 1, Curated

Manually reviewed and included in the Canada Hyperbarics research database.

Summary

What Researchers Did

Researchers reviewed the current literature on the use of hyperbaric oxygen therapy as an adjunctive treatment for intracranial abscesses.

What They Found

Intracranial abscesses, including cerebral, subdural, and epidural empyema, are associated with high morbidity and mortality. The review suggests that hyperbaric oxygen therapy, being relatively non-invasive with a low complication rate, presents a favorable risk-benefit ratio for adjunctive use in selected patients with intracranial abscess.

Canadian Relevance

This review does not have a specific Canadian connection.

Study Limitations

As a narrative review, this study's findings are based on existing literature and do not include new primary data or a systematic analysis of evidence.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Infection
Source Pubmed
PubMed ID 33648039
Year Published 2021
Journal Undersea Hyperb Med

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology